<DOC>
	<DOC>NCT01798212</DOC>
	<brief_summary>A prospective multi center case controlled trial on the clinical feasibility of a new full thickness endoscopic plication device for patients with GERD. The primary objective of the present trial is to investigate, clinical feasibility of the GERDx™ device, evaluating surgical aspects, quality of life, and symptom sores. Secondary objective of the trail is to evaluate objective data before and after the procedure, using manometry and 24h impedeance measurement</brief_summary>
	<brief_title>Prospective Trial on the Clinical Feasibility of a New Full Thickness Endoscopic Plication Device for Patients With GERD.</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<criteria>Written informed consent; ≥ 18 years of age; GERD documented by 24h ambulatory Multichannel ImpedancepHMonitoring off antisecretory therapy and/or Gastroscopy by one or more of the following criteria: Total Number of Reflux Events ≥ 73/24h; DeMeester Score ≥ 14.7; Positive Symptom Index SI ≥ 50% for Symptoms troublesome for the Patient with a Frequency of at least 3/24hrs; Macroendoscopically distinct mucosal breaks. Patients with known immunological dysfunction (advanced liver disease, HIV, hepatitis C virus infection), drug addiction; ≤ 18 years of age; Pregnancy and lactation; Previous extensive abdominal surgery; Previous esophageal or gastric surgery; Hiatal hernia &gt;2cm; paraesophageal hernia; American Society of Anaesthesiologists physical status classification &gt;II</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>GERD</keyword>
</DOC>